A Protein Strategy for Ozempic and Wegovy Users
How to meet protein targets when appetite is suppressed on Ozempic or Wegovy. Sample meal patterns, practical tips, and why protein protects muscle.
10 min read
Read more
Articles
Clinical-trial-grounded articles on GLP-1, peptide, and metabolic medications — what's prescribed today, what's coming next, and how to make sense of the science.
How to meet protein targets when appetite is suppressed on Ozempic or Wegovy. Sample meal patterns, practical tips, and why protein protects muscle.
An honest, evidence-based guide to peptides marketed for fat loss — AOD-9604, tesamorelin, BPC-157, and others — including what evidence exists, legal status, and consumer warnings.
Ozempic and Wegovy are the same molecule — semaglutide — but with key differences in approved dose, indication, insurance, and cost. Here's the full breakdown.
Plain-English guide to next-gen weight loss drugs in late-stage trials: retatrutide, survodutide, cagrisema — what they are, how they work, and what the data shows.
Mounjaro and Zepbound are the same drug — tirzepatide — in different packaging. Here's what determines which you get, and how costs differ.
Evidence-based strategies for managing GLP-1 side effects including nausea, fatigue, constipation, and sulfur burps on Ozempic, Wegovy, or Mounjaro.
Plain-English breakdown of STEP, SURMOUNT, and SCALE trial data — what average weight loss on Wegovy, Mounjaro, and Ozempic looks like in the real world.
Why weight loss plateaus happen on Ozempic, Wegovy, and Mounjaro — the biology behind them, when to expect one, and evidence-based strategies to move forward.
GLP-1 suppresses appetite and drives weight loss. GLP-2 is a gut growth hormone for short bowel syndrome. Learn why GLP-2 is not a weight loss therapy — and what's actually true.
A complete guide to GLP-1 dose escalation — why slow titration exists, what happens at each step on Wegovy, Ozempic, Zepbound, and when to ask about pausing.
Full 2026 breakdown of GLP-1 medication costs with and without insurance — Ozempic, Wegovy, Mounjaro, Zepbound — plus savings cards, GoodRx, and compounding options.
A week-by-week guide to your first month on Ozempic, Wegovy, or Mounjaro — appetite changes, side effects, and what's normal.
How to set calorie and macro targets on Ozempic, Wegovy, or Mounjaro. Why extreme undereating backfires, muscle loss risks, and a practical nutrition framework.
A complete guide to compounded semaglutide and tirzepatide — legal status in 2026, FDA stance, safety differences vs. branded drugs, cost comparison, and what to watch for.
CagriSema Phase 3 data explained — how combining semaglutide with the amylin analog cagrilintide produced 22.7% weight loss, and why amylin matters for obesity treatment.